# US Commerce announcements: Procedures To Apply for Company-Specific Onshoring Agreements To Obtain Tariff Adjustments for Pharmaceuticals and Pharmaceutical Ingredients Under Proclamation 11020 — retained record

> Retained gov record from gov:us_commerce.

Canonical: https://highsignal.app/data/records/13f8b85b11af59ef

[← sources](https://highsignal.app/data)


source: [gov](https://highsignal.app/data/gov) (gov:us_commerce)  published 2026-05-13 00:00 ingested 2026-05-13 08:42

[original source ↗](https://www.federalregister.gov/documents/2026/05/13/2026-09489/procedures-to-apply-for-company-specific-onshoring-agreements-to-obtain-tariff-adjustments-for)

## extract

This notice announces the procedures for companies that manufacture pharmaceutical products to apply for company-specific agreements with the Department of Commerce (Commerce) to onshore manufacturing of pharmaceutical products and their ingredients. Companies that enter into such agreements are eligible for a reduced Section 232 duty rate for imports of their pharmaceutical products and associated ingredients. Companies are requested to submit applications within 30 days of publication in the Federal Register.

## retained text

No document body was retained for this record — only its metadata was stored.
